{"id":"https://openalex.org/W4414560468","doi":"https://doi.org/10.2172/2589641","title":"A lipid nanoparticle mRNA vaccine expressing the Ebola virus glycoprotein elicits strong immunological response and provides protection against challenge","display_name":"A lipid nanoparticle mRNA vaccine expressing the Ebola virus glycoprotein elicits strong immunological response and provides protection against challenge","publication_year":2024,"publication_date":"2024-12-01","ids":{"openalex":"https://openalex.org/W4414560468","doi":"https://doi.org/10.2172/2589641"},"language":"en","primary_location":{"id":"doi:10.2172/2589641","doi":"https://doi.org/10.2172/2589641","is_oa":true,"landing_page_url":"https://doi.org/10.2172/2589641","pdf_url":"https://www.osti.gov/servlets/purl/2589641","source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sandia National Laboratories (SNL), Albuquerque, NM, and Livermore, CA (United States)","raw_type":"report"},"volume":null,"type":"report","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.osti.gov/servlets/purl/2589641","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Sandia National Laboratories (SNL-CA), Livermore, CA (United States)","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I192454743","display_name":"Sandia National Laboratories California","ror":"https://ror.org/058m7ey48","country_code":"US","type":"facility","lineage":["https://openalex.org/I1330989302","https://openalex.org/I192454743","https://openalex.org/I198811213","https://openalex.org/I4210104735"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandia National Laboratories (SNL-CA), Livermore, CA (United States)","raw_affiliation_strings":["Sandia National Laboratories (SNL-CA), Livermore, CA (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sandia National Laboratories (SNL-CA), Livermore, CA (United States)","institution_ids":["https://openalex.org/I192454743"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037661722","display_name":"Elvia E. Silva","orcid":"https://orcid.org/0000-0002-2733-1999","observed_orcids":["https://orcid.org/0000-0002-2733-1999"]},"institutions":[{"id":"https://openalex.org/I192454743","display_name":"Sandia National Laboratories California","ror":"https://ror.org/058m7ey48","country_code":"US","type":"facility","lineage":["https://openalex.org/I1330989302","https://openalex.org/I192454743","https://openalex.org/I198811213","https://openalex.org/I4210104735"]},{"id":"https://openalex.org/I4210104735","display_name":"Sandia National Laboratories","ror":"https://ror.org/01apwpt12","country_code":"US","type":"facility","lineage":["https://openalex.org/I1330989302","https://openalex.org/I198811213","https://openalex.org/I4210104735"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elvia Silva","raw_affiliation_strings":["Sandia National Laboratories (SNL-CA), Livermore, CA (United States)","Sandia National Laboratories"],"raw_orcid":"https://orcid.org/0000-0002-2733-1999","affiliations":[{"raw_affiliation_string":"Sandia National Laboratories (SNL-CA), Livermore, CA (United States)","institution_ids":["https://openalex.org/I192454743"]},{"raw_affiliation_string":"Sandia National Laboratories","institution_ids":["https://openalex.org/I192454743","https://openalex.org/I4210104735"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Defense Threat Reduction Agency","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142606810","display_name":"Pacific Northwest National Laboratory","ror":"https://ror.org/05h992307","country_code":"US","type":"facility","lineage":["https://openalex.org/I1325736334","https://openalex.org/I1330989302","https://openalex.org/I142606810","https://openalex.org/I39565521"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Defense Threat Reduction Agency","raw_affiliation_strings":["Pacific Northwest National Laboratory"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pacific Northwest National Laboratory","institution_ids":["https://openalex.org/I142606810"]}]},{"author_position":"middle","author":{"id":null,"display_name":"USDOE National Nuclear Security Administration (NNSA)","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I169521973","display_name":"University of New Mexico","ror":"https://ror.org/05fs6jp91","country_code":"US","type":"education","lineage":["https://openalex.org/I169521973"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"USDOE National Nuclear Security Administration (NNSA)","raw_affiliation_strings":["University of New Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of New Mexico","institution_ids":["https://openalex.org/I169521973"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060908301","display_name":"Iris K. A. Jones","orcid":"https://orcid.org/0000-0003-4468-614X","observed_orcids":["https://orcid.org/0000-0003-4468-614X"]},"institutions":[{"id":"https://openalex.org/I192454743","display_name":"Sandia National Laboratories California","ror":"https://ror.org/058m7ey48","country_code":"US","type":"facility","lineage":["https://openalex.org/I1330989302","https://openalex.org/I192454743","https://openalex.org/I198811213","https://openalex.org/I4210104735"]},{"id":"https://openalex.org/I203172682","display_name":"Northern Arizona University","ror":"https://ror.org/0272j5188","country_code":"US","type":"education","lineage":["https://openalex.org/I203172682"]},{"id":"https://openalex.org/I4210104735","display_name":"Sandia National Laboratories","ror":"https://ror.org/01apwpt12","country_code":"US","type":"facility","lineage":["https://openalex.org/I1330989302","https://openalex.org/I198811213","https://openalex.org/I4210104735"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Iris Jones","raw_affiliation_strings":["Sandia National Laboratories","Northern Arizona University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sandia National Laboratories","institution_ids":["https://openalex.org/I192454743","https://openalex.org/I4210104735"]},{"raw_affiliation_string":"Northern Arizona University","institution_ids":["https://openalex.org/I203172682"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078391314","display_name":"Zachary R. Stromberg","orcid":"https://orcid.org/0000-0002-1137-1128","observed_orcids":["https://orcid.org/0000-0002-1137-1128"]},"institutions":[{"id":"https://openalex.org/I142606810","display_name":"Pacific Northwest National Laboratory","ror":"https://ror.org/05h992307","country_code":"US","type":"facility","lineage":["https://openalex.org/I1325736334","https://openalex.org/I1330989302","https://openalex.org/I142606810","https://openalex.org/I39565521"]},{"id":"https://openalex.org/I2801122164","display_name":"United States Army Medical Research Institute of Infectious Diseases","ror":"https://ror.org/01pveve47","country_code":"US","type":"facility","lineage":["https://openalex.org/I106965489","https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I2801122164","https://openalex.org/I2802581893"]},{"id":"https://openalex.org/I4210088792","display_name":"United States Army","ror":"https://ror.org/00afsp483","country_code":"US","type":"government","lineage":["https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I4210088792"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zachary Stromberg","raw_affiliation_strings":["Pacific Northwest National Laboratory","United States Army Medical Research Institue of Infectious Diseases (USAMRIID)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pacific Northwest National Laboratory","institution_ids":["https://openalex.org/I142606810"]},{"raw_affiliation_string":"United States Army Medical Research Institue of Infectious Diseases (USAMRIID)","institution_ids":["https://openalex.org/I2801122164","https://openalex.org/I4210088792"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059931302","display_name":"Steven B. Bradfute","orcid":"https://orcid.org/0000-0002-1985-751X","observed_orcids":["https://orcid.org/0000-0002-1985-751X"]},"institutions":[{"id":"https://openalex.org/I1282311441","display_name":"Lawrence Livermore National Laboratory","ror":"https://ror.org/041nk4h53","country_code":"US","type":"facility","lineage":["https://openalex.org/I1282311441","https://openalex.org/I1330989302","https://openalex.org/I198811213","https://openalex.org/I4210138311"]},{"id":"https://openalex.org/I169521973","display_name":"University of New Mexico","ror":"https://ror.org/05fs6jp91","country_code":"US","type":"education","lineage":["https://openalex.org/I169521973"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven Bradfute","raw_affiliation_strings":["University of New Mexico","Lawrence Livermore National Laboratory"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of New Mexico","institution_ids":["https://openalex.org/I169521973"]},{"raw_affiliation_string":"Lawrence Livermore National Laboratory","institution_ids":["https://openalex.org/I1282311441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020680432","display_name":"Jason T. Ladner","orcid":"https://orcid.org/0000-0001-7751-4366","observed_orcids":["https://orcid.org/0000-0001-7751-4366"]},"institutions":[{"id":"https://openalex.org/I1282311441","display_name":"Lawrence Livermore National Laboratory","ror":"https://ror.org/041nk4h53","country_code":"US","type":"facility","lineage":["https://openalex.org/I1282311441","https://openalex.org/I1330989302","https://openalex.org/I198811213","https://openalex.org/I4210138311"]},{"id":"https://openalex.org/I203172682","display_name":"Northern Arizona University","ror":"https://ror.org/0272j5188","country_code":"US","type":"education","lineage":["https://openalex.org/I203172682"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason Ladner","raw_affiliation_strings":["Northern Arizona University","Lawrence Livermore National Laboratory"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northern Arizona University","institution_ids":["https://openalex.org/I203172682"]},{"raw_affiliation_string":"Lawrence Livermore National Laboratory","institution_ids":["https://openalex.org/I1282311441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083611548","display_name":"Jay W. Hooper","orcid":"https://orcid.org/0000-0002-4475-0415","observed_orcids":["https://orcid.org/0000-0002-4475-0415"]},"institutions":[{"id":"https://openalex.org/I192454743","display_name":"Sandia National Laboratories California","ror":"https://ror.org/058m7ey48","country_code":"US","type":"facility","lineage":["https://openalex.org/I1330989302","https://openalex.org/I192454743","https://openalex.org/I198811213","https://openalex.org/I4210104735"]},{"id":"https://openalex.org/I2801122164","display_name":"United States Army Medical Research Institute of Infectious Diseases","ror":"https://ror.org/01pveve47","country_code":"US","type":"facility","lineage":["https://openalex.org/I106965489","https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I2801122164","https://openalex.org/I2802581893"]},{"id":"https://openalex.org/I4210088792","display_name":"United States Army","ror":"https://ror.org/00afsp483","country_code":"US","type":"government","lineage":["https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I4210088792"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jay Hooper","raw_affiliation_strings":["United States Army Medical Research Institue of Infectious Diseases (USAMRIID)","Sandia National Laboratories (SNL-CA), Livermore, CA (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"United States Army Medical Research Institue of Infectious Diseases (USAMRIID)","institution_ids":["https://openalex.org/I2801122164","https://openalex.org/I4210088792"]},{"raw_affiliation_string":"Sandia National Laboratories (SNL-CA), Livermore, CA (United States)","institution_ids":["https://openalex.org/I192454743"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040575873","display_name":"Amy Rasley","orcid":"https://orcid.org/0000-0002-4767-6628","observed_orcids":["https://orcid.org/0000-0002-4767-6628"]},"institutions":[{"id":"https://openalex.org/I1282311441","display_name":"Lawrence Livermore National Laboratory","ror":"https://ror.org/041nk4h53","country_code":"US","type":"facility","lineage":["https://openalex.org/I1282311441","https://openalex.org/I1330989302","https://openalex.org/I198811213","https://openalex.org/I4210138311"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy Rasley","raw_affiliation_strings":["Lawrence Livermore National Laboratory"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lawrence Livermore National Laboratory","institution_ids":["https://openalex.org/I1282311441"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Nicholas Fisher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1282311441","display_name":"Lawrence Livermore National Laboratory","ror":"https://ror.org/041nk4h53","country_code":"US","type":"facility","lineage":["https://openalex.org/I1282311441","https://openalex.org/I1330989302","https://openalex.org/I198811213","https://openalex.org/I4210138311"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas Fisher","raw_affiliation_strings":["Lawrence Livermore National Laboratory"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lawrence Livermore National Laboratory","institution_ids":["https://openalex.org/I1282311441"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084352079","display_name":"Oscar A Negrete","orcid":"https://orcid.org/0000-0001-8281-4777","observed_orcids":["https://orcid.org/0000-0001-8281-4777"]},"institutions":[{"id":"https://openalex.org/I192454743","display_name":"Sandia National Laboratories California","ror":"https://ror.org/058m7ey48","country_code":"US","type":"facility","lineage":["https://openalex.org/I1330989302","https://openalex.org/I192454743","https://openalex.org/I198811213","https://openalex.org/I4210104735"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Oscar Negrete","raw_affiliation_strings":["Sandia National Laboratories (SNL-CA), Livermore, CA (United States)"],"raw_orcid":"https://orcid.org/0000-0001-8281-4777","affiliations":[{"raw_affiliation_string":"Sandia National Laboratories (SNL-CA), Livermore, CA (United States)","institution_ids":["https://openalex.org/I192454743"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11581","display_name":"Viral Infections and Outbreaks Research","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11581","display_name":"Viral Infections and Outbreaks Research","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11135","display_name":"Virology and Viral Diseases","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ebola-virus","display_name":"Ebola virus","score":0.675000011920929},{"id":"https://openalex.org/keywords/zaire-ebolavirus","display_name":"Zaire ebolavirus","score":0.8999999761581421},{"id":"https://openalex.org/keywords/ebola-virus-glycoprotein","display_name":"Ebola virus glycoprotein","score":0.6729999780654907},{"id":"https://openalex.org/keywords/lipid-nanoparticle-mrna-vaccines","display_name":"lipid nanoparticle mRNA vaccine","score":0.9710000157356262},{"id":"https://openalex.org/keywords/prime-boost-vaccination","display_name":"prime-boost vaccination","score":0.824999988079071},{"id":"https://openalex.org/keywords/immunodeficient-mice","display_name":"immunodeficient mice","score":0.8069999814033508},{"id":"https://openalex.org/keywords/cross-protection","display_name":"cross-protection","score":0.7049999833106995},{"id":"https://openalex.org/keywords/pre-exposure-prophylaxis","display_name":"pre-exposure prophylaxis","score":0.8429999947547913},{"id":"https://openalex.org/keywords/vaccine-immunogenicity","display_name":"vaccine immunogenicity","score":0.7149999737739563},{"id":"https://openalex.org/keywords/protection-against-challenge","display_name":"challenge protection","score":0.593999981880188}],"concepts":[{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6899999976158142},{"id":"https://openalex.org/C2777469322","wikidata":"https://www.wikidata.org/wiki/Q8064876","display_name":"Ebola virus","level":3,"score":0.6017000079154968},{"id":"https://openalex.org/C108625454","wikidata":"https://www.wikidata.org/wiki/Q187126","display_name":"Glycoprotein","level":2,"score":0.5189999938011169},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4968999922275543},{"id":"https://openalex.org/C105580179","wikidata":"https://www.wikidata.org/wiki/Q188928","display_name":"Messenger RNA","level":3,"score":0.47510001063346863},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.4462999999523163},{"id":"https://openalex.org/C2778933410","wikidata":"https://www.wikidata.org/wiki/Q3553092","display_name":"Ebola vaccine","level":4,"score":0.44110000133514404},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4368000030517578},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34880000352859497},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.32089999318122864},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.3156000077724457},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.31130000948905945},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.30880001187324524},{"id":"https://openalex.org/C2776387124","wikidata":"https://www.wikidata.org/wiki/Q1475781","display_name":"Virus-like particle","level":4,"score":0.30630001425743103},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.27239999175071716},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.26840001344680786},{"id":"https://openalex.org/C167508917","wikidata":"https://www.wikidata.org/wiki/Q578537","display_name":"DNA vaccination","level":4,"score":0.2605000138282776},{"id":"https://openalex.org/C3018913218","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody response","level":3,"score":0.25619998574256897},{"id":"https://openalex.org/C2776789287","wikidata":"https://www.wikidata.org/wiki/Q7166532","display_name":"Peptide vaccine","level":4,"score":0.2554999887943268},{"id":"https://openalex.org/C2779341262","wikidata":"https://www.wikidata.org/wiki/Q182581","display_name":"Immunity","level":3,"score":0.25270000100135803}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2172/2589641","doi":"https://doi.org/10.2172/2589641","is_oa":true,"landing_page_url":"https://doi.org/10.2172/2589641","pdf_url":"https://www.osti.gov/servlets/purl/2589641","source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sandia National Laboratories (SNL), Albuquerque, NM, and Livermore, CA (United States)","raw_type":"report"}],"best_oa_location":{"id":"doi:10.2172/2589641","doi":"https://doi.org/10.2172/2589641","is_oa":true,"landing_page_url":"https://doi.org/10.2172/2589641","pdf_url":"https://www.osti.gov/servlets/purl/2589641","source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sandia National Laboratories (SNL), Albuquerque, NM, and Livermore, CA (United States)","raw_type":"report"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G11630931","display_name":null,"funder_award_id":"DENA0003525","funder_id":"https://openalex.org/F4320306084","funder_display_name":"U.S. Department of Energy"},{"id":"https://openalex.org/G2214935549","display_name":null,"funder_award_id":"NA0003525","funder_id":"https://openalex.org/F4320338291","funder_display_name":"Sandia National Laboratories"},{"id":"https://openalex.org/G413247060","display_name":null,"funder_award_id":"DE\u2010NA,0003525","funder_id":"https://openalex.org/F4320338291","funder_display_name":"Sandia National Laboratories"},{"id":"https://openalex.org/G4903105778","display_name":null,"funder_award_id":"NA0003525","funder_id":"https://openalex.org/F4320306084","funder_display_name":"U.S. Department of Energy"},{"id":"https://openalex.org/G5339743583","display_name":null,"funder_award_id":"NA0003525","funder_id":"https://openalex.org/F4320332369","funder_display_name":"National Nuclear Security Administration"},{"id":"https://openalex.org/G855168022","display_name":null,"funder_award_id":"DENA-0003525","funder_id":"https://openalex.org/F4320332369","funder_display_name":"National Nuclear Security Administration"}],"funders":[{"id":"https://openalex.org/F4320306084","display_name":"U.S. Department of Energy","ror":"https://ror.org/01bj3aw27"},{"id":"https://openalex.org/F4320332369","display_name":"National Nuclear Security Administration","ror":"https://ror.org/03sk1we31"},{"id":"https://openalex.org/F4320338291","display_name":"Sandia National Laboratories","ror":"https://ror.org/01apwpt12"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4414560468.pdf","grobid_xml":"https://content.openalex.org/works/W4414560468.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7106222856","https://openalex.org/W7118166452","https://openalex.org/W4416446402","https://openalex.org/W2286448385","https://openalex.org/W2567617868","https://openalex.org/W2790700860","https://openalex.org/W7098956072","https://openalex.org/W2777795488","https://openalex.org/W4313344597","https://openalex.org/W2980312917"],"abstract_inverted_index":{"Zaire":[0],"Ebola":[1],"virus":[2,10,38],"(ZEBOV)":[3],"is":[4,71,77],"the":[5,41,74,84,108],"causative":[6],"agent":[7],"behind":[8],"ebola":[9],"disease":[11,14],"(EVD),":[12],"a":[13,20,35,101,116,120,128],"characterized":[15],"by":[16],"hemorrhagic":[17],"fever":[18],"and":[19,34,44,56,76,91,111,135],"high":[21],"case":[22],"fatality":[23],"rate.Current":[24],"countermeasures":[25],"for":[26,79],"EVD":[27,64,96],"are":[28],"limited":[29],"to":[30],"monoclonal":[31],"antibody":[32],"therapies,":[33],"vesicular":[36],"stomatitis":[37],"(VSV)-vectored":[39],"vaccine.Although":[40],"available":[42],"therapies":[43],"vaccine":[45,70,106,125,131],"have":[46],"shown":[47],"promise":[48],"during":[49],"recent":[50],"ZEBOV":[51],"outbreaks,":[52],"long":[53],"term":[54],"protection":[55],"cross-protection":[57],"against":[58],"other":[59],"viral":[60],"species":[61],"associated":[62],"with":[63],"remain":[65],"unknown.The":[66],"rVSV-ZEBOV":[67],"glycoprotein":[68],"(gp)":[69],"currently":[72],"considered":[73],"gold-standard":[75],"recommended":[78],"pre-exposure":[80],"prophylactic":[81],"use":[82],"in":[83,95,132],"US":[85],"among":[86],"high-risk":[87],"populations,":[88],"including":[89],"military":[90],"health-care":[92],"workers":[93],"deployed":[94],"response":[97],"areas.Here,":[98],"we":[99],"developed":[100],"lipid":[102,121],"nanoparticle":[103,122],"(LNP)":[104,123],"mRNA":[105,124],"expressing":[107],"EBOVgp":[109],"antigen":[110],"compared":[112],"immunological":[113],"responses":[114],"from":[115],"prime-boost":[117],"regimen":[118],"of":[119],"formulation":[126],"versus":[127],"rVSV-EBOVgp":[129],"platform":[130],"wild":[133],"type":[134],"immunocompromised":[136],"mouse":[137],"models.":[138]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2025-09-27T00:00:00"}